Acorn Wealth Advisors’s Sorrento Therapeutics, Inc. SRNE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q1 | – | Sell |
-33,194
| Closed | -$29K | – | 172 |
|
|
2022
Q4 | $29K | Buy |
33,194
+410
| +1% | +$358 | 0.02% | 158 |
|
|
2022
Q3 | $51K | Buy |
32,784
+574
| +2% | +$893 | 0.04% | 154 |
|
|
2022
Q2 | $65K | Buy |
32,210
+8,192
| +34% | +$16.5K | 0.05% | 160 |
|
|
2022
Q1 | $56K | Buy |
24,018
+8,704
| +57% | +$20.3K | 0.04% | 172 |
|
|
2021
Q4 | $71K | Buy |
15,314
+1,076
| +8% | +$4.99K | 0.05% | 179 |
|
|
2021
Q3 | $109K | Buy |
14,238
+3,948
| +38% | +$30.2K | 0.08% | 171 |
|
|
2021
Q2 | $100K | Buy |
+10,290
| New | +$100K | 0.07% | 166 |
|